Abstract
Initial evidence suggested that people with Complex Regional Pain Syndrome (CRPS) have reduced attention to the affected side of their body and the surrounding space, which might be related to pain and other clinical symptoms. Three previous unblinded, uncontrolled studies showed pain relief following treatment with prism adaptation, an intervention that has been used to counter lateralised attention bias in brain-lesioned patients. To provide a robust test of its effectiveness for CRPS, we conducted a double-blind randomized controlled trial of prism adaptation for unilateral upper-limb CRPS-I. Forty-nine eligible adults with CRPS were randomized to undergo two-weeks of twice-daily home-based prism adaptation treatment (n = 23) or sham treatment (n = 26). Outcomes were assessed in person four weeks prior to and immediately before treatment, and immediately after and four weeks post-treatment. Long-term postal follow-ups were conducted three and six months after treatment. We examined the effects of prism adaptation versus sham treatment on current pain intensity and CRPS symptom severity score (primary outcomes); as well as sensory, motor, and autonomic functions, self-reported psychological functioning, and experimentally tested neuropsychological functions (secondary outcomes). We found no evidence that primary or secondary outcomes differed between the prism adaptation and sham treatment groups when tested at either time point following treatment. Overall, CRPS severity significantly decreased over time for both groups, but we found no benefits of prism adaptation beyond sham treatment. Our findings do not support the efficacy of prism adaptation treatment for relieving upper-limb CRPS-I. This trial was prospectively registered (ISRCTN46828292).
Competing Interest Statement
MH and ADV were supported by studentships from the University of Bath and the GW4 BioMed Medical Research Council Doctoral Training Partnership (ref. 1793344), respectively. HM and AG have received support from the Pain Relief Foundation, Liverpool. AG, LH, and JB are committee members of the CRPS UK Research Network. LH is a committee member of the Physiotherapy Pain Association and the British Pain Society. The authors have no other competing interests to declare.
Clinical Trial
ISRCTN46828292
Clinical Protocols
https://doi.org/10.1186/ISRCTN46828292
https://doi.org/10.1186/s12883-020-1604-z
Funding Statement
The study was supported by a grant from the Reflex Sympathetic Dystrophy Syndrome Association (RSDSA) awarded to JHB and MJP. The RSDSA approved the design of the study. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of interest: MH and ADV were supported by studentships from the University of Bath and the GW4 BioMed Medical Research Council Doctoral Training Partnership (ref. 1793344), respectively. HM and AG have received support from the Pain Relief Foundation, Liverpool. AG, LH, and JB are committee members of the CRPS UK Research Network. LH is a committee member of the Physiotherapy Pain Association and the British Pain Society. The authors have no other competing interests to declare.
Previous presentation of the research: Oral presentations of the preliminary results were delivered at the UK Sensorimotor Conference in London, UK (2019) and the Pain Research Meeting in Brussels, Belgium (2019).
Data Availability
Anonymised participant-level data generated during the current trial (https://osf.io/ba6fq/), digital study materials (training protocol and video, PsychoPy experiment files and stimuli; https://osf.io/7fk2v/), and analysis scripts (https://osf.io/w67rx/) are publicly available in an Open Science Framework repository.